1.85 Eli Lilly stock will surge 29% over the next year with its weight-loss drug on pace to do $60 billion in sales by 2030, BofA says

News


<< back

Eli Lilly stock will surge 29% over the next year with its weight-loss drug on pace to do $60 billion in sales by 2030, BofA says
Date: 2024-03-02 [news.yahoo.com]

READ THE FULL NEWS >>
×